25 XP   0   0   10

Unity Biotechnology Inc
Buy, Hold or Sell?

Let's analyze Unity Biotechnology Inc together

I guess you are interested in Unity Biotechnology Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Unity Biotechnology Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Unity Biotechnology Inc

I send you an email if I find something interesting about Unity Biotechnology Inc.

Quick analysis of Unity Biotechnology Inc (30 sec.)










What can you expect buying and holding a share of Unity Biotechnology Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$1.69
Expected worth in 1 year
$-0.11
How sure are you?
23.3%

+ What do you gain per year?

Total Gains per Share
$-1.80
Return On Investment
-139.6%

For what price can you sell your share?

Current Price per Share
$1.29
Expected price per share
$1.22 - $1.63
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Unity Biotechnology Inc (5 min.)




Live pricePrice per Share (EOD)

$1.29

Intrinsic Value Per Share

$2.05 - $3.57

Total Value Per Share

$3.74 - $5.27

2. Growth of Unity Biotechnology Inc (5 min.)




Is Unity Biotechnology Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$28.3m$60.9m-$25.3m-71.3%

How much money is Unity Biotechnology Inc making?

Current yearPrevious yearGrowGrow %
Making money-$8.3m-$13.5m$5.2m62.4%
Net Profit Margin-57.0%-27.2%--

How much money comes from the company's main activities?

3. Financial Health of Unity Biotechnology Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#506 / 966

Most Revenue
#566 / 966

Most Profit
#521 / 966

Most Efficient
#415 / 966
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Unity Biotechnology Inc? (5 min.)

Welcome investor! Unity Biotechnology Inc's management wants to use your money to grow the business. In return you get a share of Unity Biotechnology Inc.

What can you expect buying and holding a share of Unity Biotechnology Inc?

First you should know what it really means to hold a share of Unity Biotechnology Inc. And how you can make/lose money.

Speculation

The Price per Share of Unity Biotechnology Inc is $1.29. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Unity Biotechnology Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Unity Biotechnology Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.69. Based on the TTM, the Book Value Change Per Share is $-0.45 per quarter. Based on the YOY, the Book Value Change Per Share is $0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Unity Biotechnology Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.26-20.0%-0.50-38.5%-0.77-59.9%-0.96-74.4%-0.98-75.8%
Usd Book Value Change Per Share0.000.0%-0.45-34.9%0.129.2%-0.35-27.3%0.064.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.118.5%
Usd Total Gains Per Share0.000.0%-0.45-34.9%0.129.2%-0.35-27.3%0.1712.8%
Usd Price Per Share1.64-2.13-1.33-3.80-4.39-
Price to Earnings Ratio-1.59--2.13--0.44--1.18--1.18-
Price-to-Total Gains Ratio-3.95--1.99--2.43--3.80-
Price to Book Ratio0.97-1.02-0.37-0.83-0.74-
Price-to-Total Gains Ratio-3.95--1.99--2.43--3.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.29
Number of shares775
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.45-0.35
Usd Total Gains Per Share-0.45-0.35
Gains per Quarter (775 shares)-348.85-272.75
Gains per Year (775 shares)-1,395.40-1,091.01
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1395-14050-1091-1101
20-2791-28000-2183-2192
30-4186-41951-3274-3283
40-5582-55901-4365-4374
50-6977-69851-5456-5465
60-8372-83801-6548-6556
70-9768-97752-7639-7647
80-11163-111702-8730-8738
90-12559-125652-9821-9829
100-13954-139602-10913-10920

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.029.00.03.3%1.029.00.03.3%
Book Value Change Per Share0.03.01.00.0%2.09.01.016.7%4.015.01.020.0%7.019.04.023.3%7.019.04.023.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.019.05.0%3.00.027.010.0%3.00.027.010.0%
Total Gains per Share0.03.01.00.0%2.09.01.016.7%4.015.01.020.0%7.019.04.023.3%7.019.04.023.3%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Unity Biotechnology Inc

About Unity Biotechnology Inc

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase 2 clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2048, a Tie2/VEGF bispecific; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.

Fundamental data was last updated by Penke on 2024-06-19 09:37:07.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Unity Biotechnology Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Unity Biotechnology Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Unity Biotechnology Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -228.1% means that $-2.28 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Unity Biotechnology Inc:

  • The MRQ is -228.1%. The company is making a huge loss. -2
  • The TTM is -57.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-228.1%TTM-57.0%-171.1%
TTM-57.0%YOY-27.2%-29.8%
TTM-57.0%5Y-28.0%-29.0%
5Y-28.0%10Y-48.9%+20.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-228.1%-168.0%-60.1%
TTM-57.0%-209.9%+152.9%
YOY-27.2%-242.3%+215.1%
5Y-28.0%-401.7%+373.7%
10Y-48.9%-532.2%+483.3%
1.1.2. Return on Assets

Shows how efficient Unity Biotechnology Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Unity Biotechnology Inc to the Biotechnology industry mean.
  • -6.6% Return on Assets means that Unity Biotechnology Inc generated $-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Unity Biotechnology Inc:

  • The MRQ is -6.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.6%TTM-10.8%+4.2%
TTM-10.8%YOY-11.6%+0.9%
TTM-10.8%5Y-12.6%+1.9%
5Y-12.6%10Y-12.8%+0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.6%-11.9%+5.3%
TTM-10.8%-11.9%+1.1%
YOY-11.6%-11.3%-0.3%
5Y-12.6%-13.5%+0.9%
10Y-12.8%-14.9%+2.1%
1.1.3. Return on Equity

Shows how efficient Unity Biotechnology Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Unity Biotechnology Inc to the Biotechnology industry mean.
  • -15.3% Return on Equity means Unity Biotechnology Inc generated $-0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Unity Biotechnology Inc:

  • The MRQ is -15.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -21.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.3%TTM-21.9%+6.6%
TTM-21.9%YOY-23.6%+1.7%
TTM-21.9%5Y-23.1%+1.2%
5Y-23.1%10Y-19.4%-3.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.3%-14.2%-1.1%
TTM-21.9%-15.7%-6.2%
YOY-23.6%-14.3%-9.3%
5Y-23.1%-19.2%-3.9%
10Y-19.4%-19.7%+0.3%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Unity Biotechnology Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Unity Biotechnology Inc is operating .

  • Measures how much profit Unity Biotechnology Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Unity Biotechnology Inc to the Biotechnology industry mean.
  • An Operating Margin of -414.1% means the company generated $-4.14  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Unity Biotechnology Inc:

  • The MRQ is -414.1%. The company is operating very inefficient. -2
  • The TTM is -103.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-414.1%TTM-103.5%-310.6%
TTM-103.5%YOY175.6%-279.2%
TTM-103.5%5Y3.4%-106.9%
5Y3.4%10Y-28.6%+32.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-414.1%-354.6%-59.5%
TTM-103.5%-225.9%+122.4%
YOY175.6%-252.2%+427.8%
5Y3.4%-428.3%+431.7%
10Y-28.6%-531.1%+502.5%
1.2.2. Operating Ratio

Measures how efficient Unity Biotechnology Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 4.14 means that the operating costs are $4.14 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 4.141. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.035. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.141TTM1.035+3.106
TTM1.035YOY-1.294+2.330
TTM1.0355Y0.152+0.884
5Y0.15210Y1.113-0.961
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1413.004+1.137
TTM1.0353.332-2.297
YOY-1.2943.502-4.796
5Y0.1525.271-5.119
10Y1.1136.915-5.802
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Unity Biotechnology Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Unity Biotechnology Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.94 means the company has $5.94 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 5.945. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.228. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.945TTM5.228+0.717
TTM5.228YOY4.794+0.433
TTM5.2285Y6.474-1.246
5Y6.47410Y7.942-1.468
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9453.767+2.178
TTM5.2284.000+1.228
YOY4.7944.905-0.111
5Y6.4745.883+0.591
10Y7.9426.286+1.656
1.3.2. Quick Ratio

Measures if Unity Biotechnology Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Unity Biotechnology Inc to the Biotechnology industry mean.
  • A Quick Ratio of 8.70 means the company can pay off $8.70 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 8.696. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.761. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.696TTM6.761+1.935
TTM6.761YOY8.221-1.460
TTM6.7615Y10.496-3.735
5Y10.49610Y11.929-1.433
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.6963.054+5.642
TTM6.7613.506+3.255
YOY8.2214.756+3.465
5Y10.4965.757+4.739
10Y11.9296.338+5.591
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Unity Biotechnology Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Unity Biotechnology Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Unity Biotechnology Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.57 means that Unity Biotechnology Inc assets are financed with 56.8% credit (debt) and the remaining percentage (100% - 56.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 0.568. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.531. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.568TTM0.531+0.037
TTM0.531YOY0.491+0.040
TTM0.5315Y0.440+0.091
5Y0.44010Y0.375+0.066
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5680.330+0.238
TTM0.5310.342+0.189
YOY0.4910.287+0.204
5Y0.4400.368+0.072
10Y0.3750.382-0.007
1.4.2. Debt to Equity Ratio

Measures if Unity Biotechnology Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Unity Biotechnology Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 131.3% means that company has $1.31 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 1.313. The company is able to pay all its debts with equity. +1
  • The TTM is 1.146. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.313TTM1.146+0.167
TTM1.146YOY0.997+0.149
TTM1.1465Y0.866+0.280
5Y0.86610Y0.602+0.264
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3130.365+0.948
TTM1.1460.415+0.731
YOY0.9970.370+0.627
5Y0.8660.443+0.423
10Y0.6020.476+0.126
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Unity Biotechnology Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Unity Biotechnology Inc generates.

  • Above 15 is considered overpriced but always compare Unity Biotechnology Inc to the Biotechnology industry mean.
  • A PE ratio of -1.59 means the investor is paying $-1.59 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Unity Biotechnology Inc:

  • The EOD is -1.248. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.586. Based on the earnings, the company is expensive. -2
  • The TTM is -2.133. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.248MRQ-1.586+0.339
MRQ-1.586TTM-2.133+0.546
TTM-2.133YOY-0.436-1.697
TTM-2.1335Y-1.178-0.954
5Y-1.17810Y-1.179+0.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.248-2.341+1.093
MRQ-1.586-2.997+1.411
TTM-2.133-2.882+0.749
YOY-0.436-3.553+3.117
5Y-1.178-6.262+5.084
10Y-1.179-6.288+5.109
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Unity Biotechnology Inc:

  • The EOD is -0.715. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.909. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.089. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.715MRQ-0.909+0.194
MRQ-0.909TTM-1.089+0.181
TTM-1.089YOY-0.505-0.584
TTM-1.0895Y-1.122+0.033
5Y-1.12210Y-1.249+0.127
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.715-2.932+2.217
MRQ-0.909-3.739+2.830
TTM-1.089-3.776+2.687
YOY-0.505-4.917+4.412
5Y-1.122-7.942+6.820
10Y-1.249-8.503+7.254
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Unity Biotechnology Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.97 means the investor is paying $0.97 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Unity Biotechnology Inc:

  • The EOD is 0.763. Based on the equity, the company is cheap. +2
  • The MRQ is 0.970. Based on the equity, the company is cheap. +2
  • The TTM is 1.023. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.763MRQ0.970-0.207
MRQ0.970TTM1.023-0.053
TTM1.023YOY0.369+0.653
TTM1.0235Y0.835+0.188
5Y0.83510Y0.738+0.097
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.7631.843-1.080
MRQ0.9702.249-1.279
TTM1.0232.301-1.278
YOY0.3692.412-2.043
5Y0.8353.782-2.947
10Y0.7384.212-3.474
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Unity Biotechnology Inc.

3.1. Institutions holding Unity Biotechnology Inc

Institutions are holding 23.967% of the shares of Unity Biotechnology Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31ARCH VENTURE CORP5.98482.0528100481700
2024-03-31Alyeska Investment Group, L.P.5.47970.00939200138813182277.6018
2024-03-31Vanguard Group Inc3.31960557353-4249-0.7566
2024-03-31Geode Capital Management, LLC0.7989013413323511.784
2024-03-31Mayo Clinic0.7393.311512408100
2024-03-31BlackRock Inc0.6690112329-752-0.665
2024-03-31Renaissance Technologies Corp0.63690.000310694168770180.163
2024-03-31UBS O'Connor LLC0.41930.008370397-22303-24.0593
2024-03-31Bridgeway Capital Management, LLC0.29780.00175000000
2024-03-31Founders Fund V Management, LLC0.29297.37714917200
2024-03-31Wells Fargo & Co0.2592043521170.0391
2024-03-31Cercano Management LLC0.24560.00194123800
2024-03-31State Street Corporation0.225303782400
2024-03-31Millennium Management LLC0.224603771224274180.637
2024-03-31Morgan Stanley - Brokerage Accounts0.22280374106501.7682
2023-12-31JANE STREET GROUP, LLC0.16950284551136066.4522
2024-03-31Commonwealth Equity Services Inc0.14660.00012461210004.2351
2024-03-31Northern Trust Corp0.13450225799414.3488
2024-03-31CapTrust Financial Advisors0.10640.000117865178650
2024-03-31Susquehanna International Group, LLP0.09790164404823.0204
Total 20.470312.76313436892+981724+28.6%

3.2. Funds holding Unity Biotechnology Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-04-30Vanguard Total Stock Mkt Idx Inv2.1541036167100
2024-04-30Vanguard Institutional Extnd Mkt Idx Tr1.16020.000319478500
2024-04-30Fidelity Extended Market Index0.40830.000368552-621-0.8977
2024-03-31Bridgeway Ultra-Small Company Market0.29780.04265000000
2023-09-30BlackRock Extended Mkt Composite0.25270.00074243000
2024-03-31BlackRock Extended Equity Market K0.22060.000437030130.0351
2024-04-30Fidelity Total Market Index0.16520.00012772800
2024-05-30iShares Micro-Cap ETF0.16150.00527113-376-1.3678
2024-04-30Fidelity Series Total Market Index0.096901627600
2024-03-31NT Ext Equity Mkt Idx Fd - NL0.06840.00031148800
2024-02-29CIBC US Broad Market Index0.06330.00131063400
2024-03-31NT Ext Equity Mkt Idx Fd - L0.06020.00031010600
2024-03-31Northern Trust Extended Eq Market Idx0.06020.00031010600
2024-04-30Spartan Total Market Index Pool E0.05650.0001949200
2024-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0550.0003923250.0542
2024-04-30Fidelity Nasdaq Composite Index0.04590.0001770500
2024-04-30Schwab Total Stock Market Index0.02740459500
2024-03-31Extended Equity Market Fund M0.02720.00044568-9-0.1966
2024-04-30Spartan Extended Market Index Pool E0.02550.0002428262116.9626
2024-04-301290 VT Micro Cap K0.01510.0029253800
Total 5.4220.0556910331-3670.0%

3.3. Insider Transactions

Insiders are holding 1.333% of the shares of Unity Biotechnology Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-30Anirvan GhoshSELL11831.71
2023-10-30Anirvan GhoshSELL10241.9
2023-09-14Anirvan GhoshSELL12462.47
2023-06-26Anirvan GhoshSELL11773.2
3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Unity Biotechnology Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0.4500%0.118-100%-0.3520%0.056-100%
Book Value Per Share--1.6912.120-20%3.633-53%4.352-61%4.951-66%
Current Ratio--5.9455.228+14%4.794+24%6.474-8%7.942-25%
Debt To Asset Ratio--0.5680.531+7%0.491+16%0.440+29%0.375+52%
Debt To Equity Ratio--1.3131.146+15%0.997+32%0.866+52%0.602+118%
Dividend Per Share----0%-0%0.000-100%0.109-100%
Eps---0.258-0.496+92%-0.772+199%-0.959+271%-0.977+278%
Free Cash Flow Per Share---0.451-0.497+10%-0.709+57%-0.814+80%-0.815+81%
Free Cash Flow To Equity Per Share---0.190-0.679+258%0.047-500%-0.353+86%0.063-399%
Gross Profit Margin--1.0211.005+2%1.000+2%1.001+2%1.001+2%
Intrinsic Value_10Y_max--3.574--------
Intrinsic Value_10Y_min--2.053--------
Intrinsic Value_1Y_max---2.092--------
Intrinsic Value_1Y_min---2.056--------
Intrinsic Value_3Y_max---4.418--------
Intrinsic Value_3Y_min---4.256--------
Intrinsic Value_5Y_max---4.493--------
Intrinsic Value_5Y_min---4.331--------
Market Cap21658584.000-27%27534944.00035761848.000-23%22366265.640+23%63849673.528-57%73750332.752-63%
Net Profit Margin---2.281-0.570-75%-0.272-88%-0.280-88%-0.489-79%
Operating Margin---4.141-1.035-75%1.756-336%0.034-12259%-0.286-93%
Operating Ratio--4.1411.035+300%-1.294+131%0.152+2631%1.113+272%
Pb Ratio0.763-27%0.9701.023-5%0.369+163%0.835+16%0.738+31%
Pe Ratio-1.248+21%-1.586-2.133+34%-0.436-73%-1.178-26%-1.179-26%
Price Per Share1.290-27%1.6402.130-23%1.332+23%3.803-57%4.393-63%
Price To Free Cash Flow Ratio-0.715+21%-0.909-1.089+20%-0.505-44%-1.122+23%-1.249+37%
Quick Ratio--8.6966.761+29%8.221+6%10.496-17%11.929-27%
Return On Assets---0.066-0.108+63%-0.116+76%-0.126+91%-0.128+93%
Return On Equity---0.153-0.219+43%-0.236+55%-0.231+51%-0.194+27%
Total Gains Per Share----0.4500%0.118-100%-0.3520%0.166-100%
Usd Book Value--28398000.00035602250.000-20%60993000.000-53%73064550.000-61%83119866.667-66%
Usd Book Value Change Per Share----0.4500%0.118-100%-0.3520%0.056-100%
Usd Book Value Per Share--1.6912.120-20%3.633-53%4.352-61%4.951-66%
Usd Dividend Per Share----0%-0%0.000-100%0.109-100%
Usd Eps---0.258-0.496+92%-0.772+199%-0.959+271%-0.977+278%
Usd Free Cash Flow---7575000.000-8339500.000+10%-11902250.000+57%-13668850.000+80%-13691866.667+81%
Usd Free Cash Flow Per Share---0.451-0.497+10%-0.709+57%-0.814+80%-0.815+81%
Usd Free Cash Flow To Equity Per Share---0.190-0.679+258%0.047-500%-0.353+86%0.063-399%
Usd Market Cap21658584.000-27%27534944.00035761848.000-23%22366265.640+23%63849673.528-57%73750332.752-63%
Usd Price Per Share1.290-27%1.6402.130-23%1.332+23%3.803-57%4.393-63%
Usd Profit---4339000.000-8332750.000+92%-13535000.000+212%-16250650.000+275%-16507900.000+280%
Usd Revenue--1902000.000475500.000+300%-+100%334300.000+469%268933.333+607%
Usd Total Gains Per Share----0.4500%0.118-100%-0.3520%0.166-100%
 EOD+2 -5MRQTTM+16 -13YOY+17 -165Y+14 -1710Y+12 -23

4.2. Fundamental Score

Let's check the fundamental score of Unity Biotechnology Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.248
Price to Book Ratio (EOD)Between0-10.763
Net Profit Margin (MRQ)Greater than0-2.281
Operating Margin (MRQ)Greater than0-4.141
Quick Ratio (MRQ)Greater than18.696
Current Ratio (MRQ)Greater than15.945
Debt to Asset Ratio (MRQ)Less than10.568
Debt to Equity Ratio (MRQ)Less than11.313
Return on Equity (MRQ)Greater than0.15-0.153
Return on Assets (MRQ)Greater than0.05-0.066
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Unity Biotechnology Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.094
Ma 20Greater thanMa 501.439
Ma 50Greater thanMa 1001.499
Ma 100Greater thanMa 2001.571
OpenGreater thanClose1.310
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets65,690
Total Liabilities37,292
Total Stockholder Equity28,398
 As reported
Total Liabilities 37,292
Total Stockholder Equity+ 28,398
Total Assets = 65,690

Assets

Total Assets65,690
Total Current Assets46,605
Long-term Assets19,085
Total Current Assets
Cash And Cash Equivalents 19,803
Short-term Investments 23,398
Net Receivables 1,577
Other Current Assets 1,827
Total Current Assets  (as reported)46,605
Total Current Assets  (calculated)46,605
+/-0
Long-term Assets
Property Plant Equipment 18,063
Long Term Investments 1,952
Long-term Assets  (as reported)19,085
Long-term Assets  (calculated)20,015
+/- 930

Liabilities & Shareholders' Equity

Total Current Liabilities7,840
Long-term Liabilities29,452
Total Stockholder Equity28,398
Total Current Liabilities
Short-term Debt 3,451
Accounts payable 1,380
Other Current Liabilities 3,009
Total Current Liabilities  (as reported)7,840
Total Current Liabilities  (calculated)7,840
+/-0
Long-term Liabilities
Capital Lease Obligations 22,606
Long-term Liabilities  (as reported)29,452
Long-term Liabilities  (calculated)22,606
+/- 6,846
Total Stockholder Equity
Common Stock2
Retained Earnings -484,353
Accumulated Other Comprehensive Income -24
Other Stockholders Equity 512,773
Total Stockholder Equity (as reported)28,398
Total Stockholder Equity (calculated)28,398
+/-0
Other
Capital Stock2
Cash and Short Term Investments 43,201
Common Stock Shares Outstanding 15,744
Liabilities and Stockholders Equity 65,690
Net Debt 7,187
Net Invested Capital 23,988
Net Working Capital 30,787
Property Plant and Equipment Gross 17,292
Short Long Term Debt Total 26,990



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
96,648
0
0
0
102,024
144,102
208,456
194,721
181,375
160,797
154,210
141,678
151,221
157,787
164,698
174,971
156,319
148,185
136,263
125,691
124,712
112,469
97,593
136,393
124,350
114,255
101,008
69,270
65,690
65,690
65,69065,69069,270101,008114,255124,350136,39397,593112,469124,712125,691136,263148,185156,319174,971164,698157,787151,221141,678154,210160,797181,375194,721208,456144,102102,02400096,648
   > Total Current Assets 
93,409
0
0
0
88,880
136,439
187,621
179,816
172,965
151,840
141,427
125,873
129,487
115,233
123,537
135,690
100,866
102,041
87,608
84,726
90,504
81,483
67,822
102,724
96,535
86,381
72,966
49,538
46,605
46,605
46,60546,60549,53872,96686,38196,535102,72467,82281,48390,50484,72687,608102,041100,866135,690123,537115,233129,487125,873141,427151,840172,965179,816187,621136,43988,88000093,409
       Cash And Cash Equivalents 
89,286
0
0
0
7,298
62,754
34,165
28,897
15,399
34,249
23,113
36,768
37,473
25,059
39,592
48,581
17,807
26,842
13,498
21,994
32,905
16,446
19,442
22,576
12,736
22,972
19,118
7,876
19,803
19,803
19,80319,8037,87619,11822,97212,73622,57619,44216,44632,90521,99413,49826,84217,80748,58139,59225,05937,47336,76823,11334,24915,39928,89734,16562,7547,29800089,286
       Short-term Investments 
0
0
0
0
79,212
71,281
151,806
148,917
155,736
115,949
104,889
76,206
90,015
88,299
79,944
83,633
79,892
73,617
70,445
58,973
55,170
62,717
45,065
76,364
82,059
60,420
49,974
38,063
23,398
23,398
23,39823,39838,06349,97460,42082,05976,36445,06562,71755,17058,97370,44573,61779,89283,63379,94488,29990,01576,206104,889115,949155,736148,917151,80671,28179,2120000
       Net Receivables 
0
0
0
0
1,382
0
0
0
0
0
10,650
10,650
0
0
0
0
0
0
0
0
0
0
0
0
235
1,500
1,743
1,711
0
1,577
1,57701,7111,7431,50023500000000000010,65010,650000001,3820000
       Other Current Assets 
4,123
0
0
0
988
697
1,650
2,002
1,830
1,642
2,775
2,249
1,999
1,875
4,001
3,476
3,167
1,582
3,665
3,209
1,879
2,320
3,315
3,784
1,740
2,989
370
629
871
1,827
1,8278716293702,9891,7403,7843,3152,3201,8793,2093,6651,5823,1673,4764,0011,8751,9992,2492,7751,6421,8302,0021,6506979880004,123
   > Long-term Assets 
0
0
0
0
13,144
7,663
20,835
14,905
8,410
8,957
12,783
15,805
21,734
42,554
41,161
39,281
55,453
46,144
48,655
40,965
34,208
30,986
29,771
33,669
27,815
27,874
28,042
19,732
19,085
19,085
19,08519,08519,73228,04227,87427,81533,66929,77130,98634,20840,96548,65546,14455,45339,28141,16142,55421,73415,80512,7838,9578,41014,90520,8357,66313,1440000
       Property Plant Equipment 
2,248
0
0
0
6,958
6,591
6,595
6,345
6,238
5,880
5,658
5,359
16,636
40,510
39,117
37,833
36,136
34,908
33,667
32,464
31,228
30,014
28,813
27,717
26,867
26,053
25,242
18,836
18,063
18,063
18,06318,06318,83625,24226,05326,86727,71728,81330,01431,22832,46433,66734,90836,13637,83339,11740,51016,6365,3595,6585,8806,2386,3456,5956,5916,9580002,248
       Long Term Investments 
0
0
0
0
5,118
0
12,073
6,386
0
0
4,040
7,353
3,025
0
0
0
17,871
9,790
13,542
7,500
1,993
0
0
4,980
0
0
1,899
0
0
1,952
1,952001,899004,980001,9937,50013,5429,79017,8710003,0257,3534,040006,38612,07305,1180000
       Long-term Assets Other 
0
0
0
0
1,068
1,072
2,167
2,174
2,172
3,077
3,085
3,093
2,073
2,044
2,044
1,448
1,446
1,446
1,446
1,001
987
972
62
972
52
29
901
896
1,022
126
1261,0228969012952972629729871,0011,4461,4461,4461,4482,0442,0442,0733,0933,0853,0772,1722,1742,1671,0721,0680000
> Total Liabilities 
7,095
0
0
0
11,181
242,733
13,387
15,205
20,682
14,194
27,160
26,961
30,514
52,458
52,439
76,870
73,439
68,232
70,346
67,954
65,143
61,778
57,662
57,828
57,502
55,627
51,601
33,064
37,292
37,292
37,29237,29233,06451,60155,62757,50257,82857,66261,77865,14367,95470,34668,23273,43976,87052,43952,45830,51426,96127,16014,19420,68215,20513,387242,73311,1810007,095
   > Total Current Liabilities 
3,691
0
0
0
7,897
10,663
9,405
11,690
16,582
11,111
15,232
14,318
17,216
14,569
15,669
16,925
14,463
10,269
13,395
12,977
16,617
17,905
16,419
16,774
19,620
21,579
22,222
8,633
7,840
7,840
7,8407,8408,63322,22221,57919,62016,77416,41917,90516,61712,97713,39510,26914,46316,92515,66914,56917,21614,31815,23211,11116,58211,6909,40510,6637,8970003,691
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,520
33,264
32,036
945
3,055
4,837
7,087
6,776
9,476
12,783
13,704
0
0
3,451
3,4510013,70412,7839,4766,7767,0874,8373,05594532,03633,2644,5200000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
945
3,055
4,837
7,087
6,776
9,476
12,783
13,704
0
0
0
00013,70412,7839,4766,7767,0874,8373,0559450000000000000000000
       Accounts payable 
964
0
0
0
2,378
5,037
1,883
2,624
4,847
4,071
5,381
4,578
5,185
4,015
3,952
4,255
2,558
1,975
1,898
1,773
1,985
3,323
1,437
2,444
1,790
1,470
1,449
1,149
1,380
1,380
1,3801,3801,1491,4491,4701,7902,4441,4373,3231,9851,7731,8981,9752,5584,2553,9524,0155,1854,5785,3814,0714,8472,6241,8835,0372,378000964
       Other Current Liabilities 
2,727
0
0
0
5,519
5,626
7,522
9,066
11,735
7,040
9,851
9,740
12,031
10,554
11,717
12,670
21
8,294
11,497
10,259
11,361
9,529
7,895
7,554
8,354
7,326
7,069
7,484
10
3,009
3,009107,4847,0697,3268,3547,5547,8959,52911,36110,25911,4978,2942112,67011,71710,55412,0319,7409,8517,04011,7359,0667,5225,6265,5190002,727
   > Long-term Liabilities 
0
0
0
0
3,284
232,070
3,982
3,515
4,100
3,083
11,928
12,643
13,298
37,889
36,770
59,945
58,976
57,963
56,951
54,977
48,526
43,873
41,243
41,054
37,882
34,048
29,379
24,431
29,452
29,452
29,45229,45224,43129,37934,04837,88241,05441,24343,87348,52654,97756,95157,96358,97659,94536,77037,88913,29812,64311,9283,0834,1003,5153,982232,0703,2840000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,313
24,508
24,699
24,892
24,142
0
0
12,670
0
10,891
7,619
4,082
0
0
0
0004,0827,61910,891012,6700024,14224,89224,69924,50824,313000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
37,889
36,770
35,632
34,468
0
0
29,867
31,417
24,502
21,486
21,016
20,615
13,367
11,593
24,431
26,990
19,155
19,15526,99024,43111,59313,36720,61521,01621,48624,50231,41729,8670034,46835,63236,77037,8890000000000000
       Warrants
0
0
0
0
0
228,907
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000228,90700000
       Long-term Liabilities Other 
0
0
0
0
0
101
1,115
848
1,633
818
7
0
0
37,889
36,770
35,632
34,468
33,264
23
30,835
23
0
28,573
0
26,991
26,150
25,297
0
0
0
00025,29726,15026,991028,57302330,8352333,26434,46835,63236,77037,8890078181,6338481,11510100000
       Deferred Long Term Liability 
0
0
0
0
0
3,062
2,867
2,667
2,467
2,265
11,921
12,643
13,298
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000013,29812,64311,9212,2652,4672,6672,8673,06200000
> Total Stockholder Equity
89,553
-41,536
0
0
90,843
-98,631
195,069
179,516
160,693
146,603
127,050
114,717
120,707
105,329
112,259
98,101
82,880
79,953
65,917
57,737
59,569
50,691
39,931
78,565
66,848
58,628
49,407
36,206
28,398
28,398
28,39828,39836,20649,40758,62866,84878,56539,93150,69159,56957,73765,91779,95382,88098,101112,259105,329120,707114,717127,050146,603160,693179,516195,069-98,63190,84300-41,53689,553
   Common Stock
1
0
0
0
3
1
4
4
4
4
4
4
5
5
5
5
5
5
5
5
6
7
7
1
1
1
1
1
0
2
201111177655555555444444130001
   Retained Earnings Total Equity000-483,021-470,816-459,9510-432,07600-389,331-372,881-355,055-339,299-319,712-292,160-273,493-245,455-227,428-205,718-182,045-163,278-141,362-123,015-103,01300000
   Accumulated Other Comprehensive Income 
0
0
0
0
-104
-138
-77
-119
-95
19
113
95
90
373
232
66
5
15
5
6
-44
-176
-187
-275
-251
-150
-136
-55
0
-24
-240-55-136-150-251-275-187-176-446515566232373909511319-95-119-77-138-1040000
   Capital Surplus 
0
0
0
0
0
5,511
318,758
321,594
324,663
329,226
333,252
342,647
366,695
379,072
404,754
417,952
422,379
435,198
438,788
447,057
0
0
472,187
0
527,049
529,593
532,563
0
0
0
000532,563529,593527,0490472,18700447,057438,788435,198422,379417,952404,754379,072366,695342,647333,252329,226324,663321,594318,7585,51100000
   Treasury Stock000000000000000000000000000000
   Other Stockholders Equity 
-202
0
0
0
177,824
-224,388
109,701
126,272
324,062
167,828
178,441
200,368
366,067
378,444
404,182
417,742
82,870
434,988
438,788
447,057
459,631
469,799
472,187
524,623
527,049
529,593
532,563
534,570
0
512,773
512,7730534,570532,563529,593527,049524,623472,187469,799459,631447,057438,788434,98882,870417,742404,182378,444366,067200,368178,441167,828324,062126,272109,701-224,388177,824000-202



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-1,182
Gross Profit-1,182-1,182
 
Operating Income (+$)
Gross Profit-1,182
Operating Expense-38,983
Operating Income-40,165-40,165
 
Operating Expense (+$)
Research Development20,799
Selling General Administrative18,766
Selling And Marketing Expenses782
Operating Expense38,98340,347
 
Net Interest Income (+$)
Interest Income3,153
Interest Expense-2,452
Other Finance Cost-989
Net Interest Income-288
 
Pretax Income (+$)
Operating Income-40,165
Net Interest Income-288
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-39,860-40,470
EBIT - interestExpense = -42,617
-39,860
-37,408
Interest Expense2,452
Earnings Before Interest and Taxes (EBIT)-40,165-37,408
Earnings Before Interest and Taxes (EBITDA)-38,983
 
After tax Income (+$)
Income Before Tax-39,860
Tax Provision-0
Net Income From Continuing Ops-52,531-39,860
Net Income-39,860
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses40,165
Total Other Income/Expenses Net305288
 

Technical Analysis of Unity Biotechnology Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Unity Biotechnology Inc. The general trend of Unity Biotechnology Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Unity Biotechnology Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Unity Biotechnology Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.42 < 1.42 < 1.63.

The bearish price targets are: 1.22.

Tweet this
Unity Biotechnology Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Unity Biotechnology Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Unity Biotechnology Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Unity Biotechnology Inc. The current macd is -0.05910151.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Unity Biotechnology Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Unity Biotechnology Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Unity Biotechnology Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Unity Biotechnology Inc Daily Moving Average Convergence/Divergence (MACD) ChartUnity Biotechnology Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Unity Biotechnology Inc. The current adx is 28.80.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Unity Biotechnology Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Unity Biotechnology Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Unity Biotechnology Inc. The current sar is 1.4.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Unity Biotechnology Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Unity Biotechnology Inc. The current rsi is 34.09. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Unity Biotechnology Inc Daily Relative Strength Index (RSI) ChartUnity Biotechnology Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Unity Biotechnology Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Unity Biotechnology Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Unity Biotechnology Inc Daily Stochastic Oscillator ChartUnity Biotechnology Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Unity Biotechnology Inc. The current cci is -92.84818068.

Unity Biotechnology Inc Daily Commodity Channel Index (CCI) ChartUnity Biotechnology Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Unity Biotechnology Inc. The current cmo is -40.41788354.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Unity Biotechnology Inc Daily Chande Momentum Oscillator (CMO) ChartUnity Biotechnology Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Unity Biotechnology Inc. The current willr is -81.57894737.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Unity Biotechnology Inc Daily Williams %R ChartUnity Biotechnology Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Unity Biotechnology Inc.

Unity Biotechnology Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Unity Biotechnology Inc. The current atr is 0.07569814.

Unity Biotechnology Inc Daily Average True Range (ATR) ChartUnity Biotechnology Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Unity Biotechnology Inc. The current obv is -35,527,239.

Unity Biotechnology Inc Daily On-Balance Volume (OBV) ChartUnity Biotechnology Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Unity Biotechnology Inc. The current mfi is 20.84.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Unity Biotechnology Inc Daily Money Flow Index (MFI) ChartUnity Biotechnology Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Unity Biotechnology Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-06-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-06-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-06-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-06-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Unity Biotechnology Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Unity Biotechnology Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.094
Ma 20Greater thanMa 501.439
Ma 50Greater thanMa 1001.499
Ma 100Greater thanMa 2001.571
OpenGreater thanClose1.310
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Unity Biotechnology Inc with someone you think should read this too:
  • Are you bullish or bearish on Unity Biotechnology Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Unity Biotechnology Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Unity Biotechnology Inc

I send you an email if I find something interesting about Unity Biotechnology Inc.


Stay informed about Unity Biotechnology Inc.

Receive notifications about Unity Biotechnology Inc in your mailbox!